Arcus Biosciences price target raised to $29 from $25 at Barclays

Arcus Biosciences Price Target Raised To $29 From $25 At Barclays

2 weeks from now

Oct 25, 2024  · Barclays analyst Peter Lawson raised the firm’s price target on Arcus Biosciences (RCUS) to $29 from $25 and keeps an Overweight rating on the shares. While the HIF2alpha …

nasdaq.com

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Purchased By Barclays …

2 weeks from now

Dec 28, 2024  · Barclays lifted their price target on shares of Arcus Biosciences from $25.00 to $29.00 and gave the company an “overweight” rating in a report on Friday, October 25th. …

americanbankingnews.com

Arcus Biosciences, Inc. (NYSE:RCUS) Given Consensus Rating

2 weeks from now

Dec 27, 2024  · Finally, Barclays increased their target price on Arcus Biosciences from $25.00 to $29.00 and gave the company an "overweight" rating in a research note on Friday, October …

marketbeat.com

RCUS Analyst Actions Repot For 10/25/2024 | News Quantified

2 weeks from now

10/25/2024 Arcus Biosciences, Inc. (NYSE: RCUS) had its price target raised by analysts at Barclays PLC from $25.00 to $29.00. ... RCUS) had its price target raised by analysts at …

newsquantified.com

Arcus Anti-TIGIT Antibody Differentiated From Roche’s, Says Barclays

2 weeks from now

Nov 27, 2024  · Arcus Biosciences price target raised to $29 from $25 at Barclays The views and opinions expressed herein are the views and opinions of the author and do not necessarily …

nasdaq.com

Barclays PLC Grows Position In Arcus Biosciences, Inc ... - MarketBeat

2 weeks from now

Dec 28, 2024  · Wedbush restated an "outperform" rating and set a $36.00 price objective on shares of Arcus Biosciences in a research note on Thursday, November 7th. Barclays …

marketbeat.com

Arcus Biosciences (NYSE:RCUS) Reaches New 52-Week Low

2 weeks from now

2 days ago  · Wedbush reaffirmed an "outperform" rating and set a $36.00 target price on shares of Arcus Biosciences in a research note on Thursday, November 7th. Finally, Barclays lifted …

marketbeat.com

Arcus Biosciences, Inc. (NYSE:RCUS) Given Average ... - ETF Daily …

2 weeks from now

Dec 27, 2024  · Barclays upped their price objective on Arcus Biosciences from $25.00 to $29.00 and gave the company an “overweight” rating in a report on Friday, October 25th.

etfdailynews.com

Arcus Biosciences, Inc. (NYSE:RCUS) Receives $34.00 Consensus …

2 weeks from now

Dec 30, 2024  · Barclays increased their price target on Arcus Biosciences from $25.00 to $29.00 and gave the stock an “overweight” rating in a research report on Friday, October 25th. ...

americanbankingnews.com

Arcus Biosciences, Inc. (NYSE:RCUS) Receives $34.00 Consensus …

2 weeks from now

Dec 5, 2024  · HC Wainwright reaffirmed a “neutral” rating and set a $20.00 price target on shares of Arcus Biosciences in a research report on Wednesday, November 6th. Barclays upped their …

americanbankingnews.com

Barclays Maintains Overweight On Arcus Biosciences, Raises Price …

2 weeks from now

Oct 25, 2024  · Barclays analyst Peter Lawson maintains Arcus Biosciences (NYSE:RCUS) with a Overweight and raises the price target from $25 to $29.

sahmcapital.com

Arcus Biosciences Price Target Raised To $29 From $25 At Barclays

2 weeks from now

Oct 25, 2024  · Barclays analyst Peter Lawson raised the firm’s price target on Arcus Biosciences (RCUS) to $29 from $25 and keeps an Overweight rating on...

businessinsider.com

Barclays Issues A Buy Rating On Arcus Biosciences (RCUS)

2 weeks from now

Oct 17, 2024  · Barclays analyst Peter Lawson assigned a Buy rating to Arcus Biosciences (RCUS – Research Report) today and set a price target of $25.00.The company’s shares closed …

businessinsider.com

Barclays Increases Arcus Biosciences (NYSE:RCUS) Price Target To …

2 weeks from now

Oct 25, 2024  · Despite a recent 4.2% drop in stock price, Arcus has shown a year-over-year revenue increase of 34.5%. The company focuses on developing cancer therapies and has …

longportapp.com

Arcus Biosciences, Inc. (NYSE:RCUS) Stock Holdings Cut By UBS …

2 weeks from now

Dec 19, 2024  · HC Wainwright reaffirmed a “neutral” rating and set a $20.00 target price on shares of Arcus Biosciences in a research note on Wednesday, November 6th. Barclays …

americanbankingnews.com

Robert C. Goeltz II Sells 3,594 Shares Of Arcus Biosciences, Inc.

2 weeks from now

Jan 3, 2025  · Finally, Barclays raised their price target on Arcus Biosciences from $25.00 to $29.00 and gave the stock an "overweight" rating in a research report on Friday, October 25th. …

marketbeat.com

Arcus Biosciences, Inc. (NYSE:RCUS) Shares Bought By Jane Street …

2 weeks from now

Dec 20, 2024  · Barclays raised their price target on shares of Arcus Biosciences from $25.00 to $29.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th.

etfdailynews.com

Brokerages Set Arcus Biosciences, Inc. (NYSE:RCUS) Target Price At …

2 weeks from now

Dec 5, 2024  · Barclays upped their price objective on Arcus Biosciences from $25.00 to $29.00 and gave the stock an “overweight” rating in a research note on Friday, October 25th.

etfdailynews.com

Arcus Biosciences (RCUS) Stock Forecast And Price Target 2025

2 weeks from now

Jan 8, 2025  · According to the 9 analysts' twelve-month price targets for Arcus Biosciences, the average price target is $34.00. ... 10/25/2024: Barclays. 3 of 5 stars : Boost Target: …

marketbeat.com